TRAP1 and lung adenocarcinoma: As shown in a study by Kuchitsu et al., TRAP1 interference reduces the proliferation of lung adenocarcinoma cells and increases their sensitivity to cisplatin, indicating that TRAP1 expression may affect recurrence and chemotherapeutic resistance in patients with lung adenocarcinoma (74).